Last reviewed · How we verify
CELLISTEM-OA
At a glance
| Generic name | CELLISTEM-OA |
|---|---|
| Also known as | Mesenchymal stem cells |
| Sponsor | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intra-articular Injection of UC-MSC Exosome in Knee Osteoarthritis (EARLY_PHASE1)
- Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1) (PHASE1)
- Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis (PHASE1, PHASE2)
- Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |